Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Nahad Sedaghat"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Characteristics of livers and spleens of people with multiple sclerosis (pwMS) could constitute good biomarkers of MS-related characteristics such as the disability status. To test the hypothesis “the gross anatomical features of livers an
Externí odkaz:
https://doaj.org/article/f2e86a0b14c64312817ca4124a9b5602
Autor:
Mehdi Jafarzadeh Samani, Sanaz Ziaei, Niloofar Monjezi, Razieh Fazaeli, Nahad Sedaghat, Hesam Panahi, Shahrzad Mortazavi
Publikováno v:
Frontiers in Dentistry, Vol 21 (2024)
Objectives: The aim of the present investigation was to evaluate the possible anxiolytic effect of jasmine aromatherapy in pediatric dental procedures. Materials and Methods: A parallel randomized single-blinded placebo-controlled clinical trial w
Externí odkaz:
https://doaj.org/article/ca61ee290c5d40899cdd530ea77ef1c9
Publikováno v:
Frontiers in Dentistry, Vol 21 (2024)
Objectives: In an ideal pulpotomy, the radicular pulp remains vital, healthy, and fully encased within an odontoblastic layer. Mineral trioxide aggregate (MTA) and bone morphogenetic proteins (BMPs) have been suggested to facilitate this outcome. We
Externí odkaz:
https://doaj.org/article/d0ff13f73d6044aeb9f986b5c6624b31
Autor:
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Mehri Salari, Shiva Maleki, Alireza Amin, Nahad Sedaghat
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Some current evidence is pointing towards an association between COVID-19 and worsening of multiple sclerosis (MS), stressing the importance of preventing COVID-19 among people with MS (pwMS). However, population-based evidence re
Externí odkaz:
https://doaj.org/article/e02b09e3b073495e99a187337d91f16b
Autor:
Nahad Sedaghat, Masoud Etemadifar, Noushin Lotfi, Farnaz Sayahi, Ahmad Chitsaz, Mehri Salari, Alireza Ghasemi Movaghar
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPeople with multiple sclerosis (pwMS) on anti-CD20 therapies (aCD20) and fingolimod have shown inadequate humoral responses to COVID-19 vaccines.ObjectiveThe objective of the study was to pilot larger studies by demonstrating the safety and
Externí odkaz:
https://doaj.org/article/317ed2bfcf41454ebe45eef1eb901769
Autor:
Mohammad Minakari, Nahad Sedaghat
Publikováno v:
Clinical Case Reports, Vol 10, Iss 11, Pp n/a-n/a (2022)
Abstract A transmural esophageal tear complicated by large size and unusual location was diagnosed in a 59‐year‐old man after undergoing pneumatic balloon dilation for achalasia. It was closed with six endo‐clips. The patient recovered and was
Externí odkaz:
https://doaj.org/article/3581c117e8574b76b7877d7adce59564
Publikováno v:
Clinical Case Reports, Vol 10, Iss 9, Pp n/a-n/a (2022)
Abstract Two cases of sarcoidosis referred to our clinic with neurological symptoms. They were diagnosed with multiple sclerosis using non‐invasive studies. The first patient refused treatment and died of myocardial infarction 6 months after visiti
Externí odkaz:
https://doaj.org/article/616e33b3d310418dbadc949f1b803e99
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 10, Pp 3481-3483 (2021)
With the progress of COVID-19 vaccination programs worldwide, some new adverse events associated with the available vaccines may unfold, especially in subpopulations, representatives of whom were not included in phase I, II, and III clinical trials o
Externí odkaz:
https://doaj.org/article/50dc305aa5f94e9bbe9166f62e42f7fa
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a relatively unknown autoimmune entity. Scant reports of post-infection/vaccination anti-NMDAR encephalitis exist. We, hereby, reviewed the relevant cases and added to the literature a possib
Externí odkaz:
https://doaj.org/article/c01a24a6587f48e5bbd279772a975b54
Autor:
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Amirhossein Akhavan Sigari, Seyed Mohammad Piran Daliyeh, Mohammad Reza Maracy, Mehri Salari, Shiva Maleki, Nahad Sedaghat
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were interviewed. 16.2% of the vaccinated pwMS reported at least one neurological sym
Externí odkaz:
https://doaj.org/article/4541191d30c645af95fcc2e0291e7f38